These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 16204233

  • 21. L7 protein is a coregulator of vitamin D receptor-retinoid X receptor-mediated transactivation.
    Berghöfer-Hochheimer Y, Zurek C, Wölfl S, Hemmerich P, Munder T.
    J Cell Biochem; 1998 Apr 01; 69(1):1-12. PubMed ID: 9513041
    [Abstract] [Full Text] [Related]

  • 22. Novel roles of retinoid X receptor (RXR) and RXR ligand in dynamically modulating the activity of the thyroid hormone receptor/RXR heterodimer.
    Li D, Yamada T, Wang F, Vulin AI, Samuels HH.
    J Biol Chem; 2004 Feb 27; 279(9):7427-37. PubMed ID: 14668324
    [Abstract] [Full Text] [Related]

  • 23. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
    Whitfield GK, Selznick SH, Haussler CA, Hsieh JC, Galligan MA, Jurutka PW, Thompson PD, Lee SM, Zerwekh JE, Haussler MR.
    Mol Endocrinol; 1996 Dec 27; 10(12):1617-31. PubMed ID: 8961271
    [Abstract] [Full Text] [Related]

  • 24. The N-terminal nuclear localization sequences of liver X receptors alpha and beta bind to importin alpha and are essential for both nuclear import and transactivating functions.
    Miller A, Crumbley C, Prüfer K.
    Int J Biochem Cell Biol; 2009 Apr 27; 41(4):834-43. PubMed ID: 18773967
    [Abstract] [Full Text] [Related]

  • 25. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
    Herdick M, Steinmeyer A, Carlberg C.
    Chem Biol; 2000 Nov 27; 7(11):885-94. PubMed ID: 11094341
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
    Sneddon WB, Barry EL, Coutermarsh BA, Gesek FA, Liu F, Friedman PA.
    Cell Physiol Biochem; 1998 Nov 27; 8(5):261-77. PubMed ID: 9792954
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P, Barmina O, Chang CY, McDonnell DP, Shevde NK, Pike JW.
    J Bone Miner Res; 2002 Dec 27; 17(12):2196-205. PubMed ID: 12469913
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions.
    Thompson PD, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR.
    J Biol Chem; 1998 Apr 03; 273(14):8483-91. PubMed ID: 9525962
    [Abstract] [Full Text] [Related]

  • 32. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
    Pogenberg V, Guichou JF, Vivat-Hannah V, Kammerer S, Pérez E, Germain P, de Lera AR, Gronemeyer H, Royer CA, Bourguet W.
    J Biol Chem; 2005 Jan 14; 280(2):1625-33. PubMed ID: 15528208
    [Abstract] [Full Text] [Related]

  • 33. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
    Staal A, van Wijnen AJ, Birkenhäger JC, Pols HA, Prahl J, DeLuca H, Gaub MP, Lian JB, Stein GS, van Leeuwen JP, Stein JL.
    Mol Endocrinol; 1996 Nov 14; 10(11):1444-56. PubMed ID: 8923469
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Vitamin D receptor and retinoid X receptor interactions in motion.
    Barsony J, Prufer K.
    Vitam Horm; 2002 Nov 14; 65():345-76. PubMed ID: 12481554
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
    Herdick M, Carlberg C.
    J Mol Biol; 2000 Dec 15; 304(5):793-801. PubMed ID: 11124027
    [Abstract] [Full Text] [Related]

  • 38. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs.
    Quack M, Carlberg C.
    Mol Pharmacol; 1999 Jun 15; 55(6):1077-87. PubMed ID: 10347251
    [Abstract] [Full Text] [Related]

  • 39. Inhibitory effect of NF-kappaB on 1,25-dihydroxyvitamin D(3) and retinoid X receptor function.
    Farmer PK, He X, Schmitz ML, Rubin J, Nanes MS.
    Am J Physiol Endocrinol Metab; 2000 Jul 15; 279(1):E213-20. PubMed ID: 10893342
    [Abstract] [Full Text] [Related]

  • 40. Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor.
    Jurutka PW, MacDonald PN, Nakajima S, Hsieh JC, Thompson PD, Whitfield GK, Galligan MA, Haussler CA, Haussler MR.
    J Cell Biochem; 2002 Jul 15; 85(2):435-57. PubMed ID: 11948698
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.